tirzepatide glp 1 and gip Tirzepatide's Unique Mechanism of Action 1+GIP — tailored just to you. Systemic effects of tirzepatide dually

Trulicity (dulaglutide): A new GLP-1 receptor agonist once-weekly subcutaneous injection approved for the treatment of patients with Type 2 diabetes

While gradual dose titration is common, using GLP-1s at micro-doses specifically for menopause is currently unapproved and the long-term risks are unknown

Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats

LIRA: liraglutida

While every plan is personalized, nutrition counseling often follows a supportive progression like this: Getting Started: Building a Strong Foundation In your initial sessions, we take time to understand your medical history, GLP-1 medication use, goals, and current challenges

Depending on the patient, monitoring may include: Weight trends Waist circumference Blood pressure Glucose and A1C Lipids Liver markers Kidney markers Thyroid markers when appropriate Nutrient markers when indicated Hormone considerations when relevant Adjust the Plan as the Body Changes A patients needs at the start of treatment may not be the same after losing 20, 40, or 60 pounds